Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Does not alter current VF management; leaves open mechanistic studies on wave instability before therapeutic translation.
Device therapy with implantable cardioverter-defibrillators is currently the only proven effective therapy against sudden cardiac death due to ventricular fibrillation. However, the expanded clinical indications for device therapy come at a staggering cost to an already overburdened health care system. Given these statistics, it is both highly desirable and economically imperative to develop alternative therapies. New insights into the mechanisms of ventricular fibrillation, particularly the role of dynamic factors causing wave instability, are providing a promising avenue for developing novel therapies to prevent sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Weiss et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: